Olaf T Hardt

6PUBLICATIONS
18CO-AUTHORS
Molecular targetsHybrid and electric vehicles and powertrainsCancer cell biologyIndustrial molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 16, 2025
Triple-Negative Breast Cancer Unveiled: Bridging Science, Treatment Strategy, and Economic Aspects.

Valeriia Lebedeva, Mira Ebbinghaus, José Villacorta Hidalgo

|Jan 11, 2024
Endogenous Signaling Molecule Activating (ESMA) CARs: A Novel CAR Design Showing a Favorable Risk to Potency Ratio for the Treatment of Triple Negative Breast Cancer.

Mira Ebbinghaus, Katharina Wittich, Benjamin Bancher

|Jun 10, 2023
Targeting Stage-Specific Embryonic Antigen 4 (SSEA-4) in Triple Negative Breast Cancer by CAR T Cells Results in Unexpected on Target/off Tumor Toxicities in Mice.

Rita Pfeifer, Wa'el Al Rawashdeh, Janina Brauner

|Jan 13, 2023
Basal-like mammary carcinomas stimulate cancer stem cell properties through AXL-signaling to induce chemotherapy resistance.

Garyfallia Pantelaiou-Prokaki, Oliver Reinhardt, Nadine S Georges

|Sep 23, 2022
Isolation of Hepatocytes from Liver Tissue by a Novel, Semi-Automated Perfusion Technology.

Carsten Poggel, Timo Adams, Ronald Janzen

|Mar 06, 2021
Identification of CD318, TSPAN8 and CD66c as target candidates for CAR T cell based immunotherapy of pancreatic adenocarcinoma.

Daniel Schäfer, Stefan Tomiuk, Laura N Küster

Pageof 1

Frequent Collaborators

2 joint publications

Frauke Alves

2 joint publications

Valeriia Lebedeva

1 joint publications

Christoph Herbel

1 joint publications

Julia Schüler